IMUGENE CHART. TA only, page-11012

Hi Slick - I do have a protection plan - but it’s not to simply sell without regard for the corporate developments and information on trials. They shape my thinking as I don’t look at the company only via charting algorithms. Hence why simply selling at any price to recoup investment isn’t the only answer in my view. Am at a loss as to your comment on no CGT impact incentive for LTH. I guess we have quite different views which is why there are so many advisers in the zone and will leave it at that. If there were one way we would all follow it. Good luck Slick as we all are hoping for IMU success. Thanks.